Oramed Pharmaceuticals Inc (ORMP)
2.39
-0.10
(-4.02%)
USD |
NASDAQ |
May 07, 14:06
Oramed Pharmaceuticals Free Cash Flow (Quarterly): -1.421M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.421M |
| September 30, 2023 | -0.726M |
| June 30, 2023 | -2.654M |
| March 31, 2023 | -5.748M |
| December 31, 2022 | -8.37M |
| September 30, 2022 | -2.362M |
| June 30, 2022 | -8.51M |
| March 31, 2022 | -9.172M |
| November 30, 2021 | -6.903M |
| August 31, 2021 | -6.169M |
| May 31, 2021 | -5.64M |
| February 28, 2021 | -3.282M |
| November 30, 2020 | -6.465M |
| August 31, 2020 | -2.537M |
| May 31, 2020 | -3.357M |
| February 29, 2020 | -3.629M |
| November 30, 2019 | -2.999M |
| August 31, 2019 | -3.269M |
| May 31, 2019 | -3.663M |
| February 28, 2019 | -1.884M |
| November 30, 2018 | -4.139M |
| August 31, 2018 | -4.65M |
| May 31, 2018 | -3.805M |
| February 28, 2018 | -3.479M |
| November 30, 2017 | -2.728M |
| Date | Value |
|---|---|
| August 31, 2017 | -2.05M |
| May 31, 2017 | -2.359M |
| February 28, 2017 | -2.927M |
| November 30, 2016 | 1.498M |
| August 31, 2016 | 6.803M |
| May 31, 2016 | -2.232M |
| February 29, 2016 | 2.324M |
| November 30, 2015 | -2.249M |
| August 31, 2015 | -1.028M |
| May 31, 2015 | -0.914M |
| February 28, 2015 | -1.604M |
| November 30, 2014 | -1.401M |
| August 31, 2014 | -0.804M |
| May 31, 2014 | -1.039M |
| February 28, 2014 | -1.486M |
| November 30, 2013 | -0.753M |
| August 31, 2013 | -0.2822M |
| May 31, 2013 | -1.054M |
| February 28, 2013 | -1.273M |
| November 30, 2012 | -0.7928M |
| August 31, 2012 | -0.3416M |
| May 31, 2012 | -0.8837M |
| February 29, 2012 | -0.5936M |
| November 30, 2011 | -0.4841M |
| August 31, 2011 | -0.4229M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.172M
Minimum
Mar 2022
-0.726M
Maximum
Sep 2023
-4.572M
Average
-3.629M
Median
Feb 2020
Free Cash Flow (Quarterly) Benchmarks
| Inogen Inc | -9.45M |
| Petros Pharmaceuticals Inc | -2.260M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |